Van Hulzen Asset Management’s Edwards Lifesciences EW Stock Holding History

Van Hulzen Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.72M	Hold	34,024	–	–	0.2%	86
2025 Q4	$2.9M	Hold	34,024	–	–	0.21%	83
2025 Q3	$2.65M	Sell	34,024 -15	-0%	-$1.17K	0.2%	85
2025 Q2	$2.66M	Buy	34,039 +39	+0.1%	+$2.91K	0.22%	83
2025 Q1	$2.46M	Sell	34,000 -132	-0.4%	-$9.45K	0.22%	86
2024 Q4	$2.53M	Buy	34,132 +132	+0.4%	+$9.24K	0.18%	97
2024 Q3	$2.24M	Hold	34,000	–	–	0.16%	104
2024 Q2	$3.14M	Sell	34,000 -2,110	-6%	-$187K	0.21%	78
2024 Q1	$3.45M	Buy	36,110 +110	+0.3%	+$9.24K	0.23%	82
2023 Q4	$2.75M	Hold	36,000	–	–	0.19%	86
2023 Q3	$2.49M	Hold	36,000	–	–	0.19%	86
2023 Q2	$3.4M	Hold	36,000	–	–	0.29%	70
2023 Q1	$2.98M	Sell	36,000 -80	-0.2%	-$6.29K	0.28%	71
2022 Q4	$2.69M	Sell	36,080 -400	-1%	-$30.8K	0.31%	71
2022 Q3	$3.01M	Sell	36,480 -300	-0.8%	-$28.9K	0.37%	67
2022 Q2	$3.5M	Buy	36,780 +80	+0.2%	+$8.28K	0.42%	64
2022 Q1	$4.32M	Hold	36,700	–	–	0.46%	61
2021 Q4	$4.75M	Buy	+36,700	New	+$4.28M	0.52%	55

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Van Hulzen Asset Management's EW Position: Q1 2026 in Review

Van Hulzen Asset Management held its Edwards Lifesciences (EW) position steady in Q1 2026 at 34,024 shares worth $2.72M. The position accounts for 0.2% of the portfolio, ranked #86.

Van Hulzen Asset Management first reported a position in EW in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.75M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Van Hulzen Asset Management held 34,024 shares of Edwards Lifesciences worth $2.72M as of Q1 2026.
Van Hulzen Asset Management left its Edwards Lifesciences share count unchanged in Q1 2026.
Edwards Lifesciences made up 0.2% of Van Hulzen Asset Management's portfolio in Q1 2026, its #86 holding.
Van Hulzen Asset Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
Van Hulzen Asset Management's Edwards Lifesciences position peaked at $4.75M in Q4 2021.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Van Hulzen Asset Management's 13F filing for Q1 2026, filed 14 May 2026.